StemCyte
Blood & Organ Banks · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
13800 Live Oak Ave, Baldwin Park, Califo...Phone Number
(626) 646-2500Website
www.stemcyte.comRevenue
$18.1 MillionIndustry
ZI Rank: 4
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
2
3
3
4
About StemCyte
StemCyte is a leading cord blood bank trusted by OBGYN and transplant physicians, specializing in the storage of newborn stem cells. The company offers both private and public bank access, enabling families to preserve their child's cord blood for potential life-saving treatments. StemCyte is known for its extensive and ethnically diverse inventory, participating in numerous clinical trials and achieving impressive transplant records. Its services aim to provide parents with peace of mind regarding the future health of their children and the possibility of treatment for various diseases.Explore more
StemCyte Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is StemCyte your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if StemCyte is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
StemCyte, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when StemCyte launches new products
Click to see if StemCyte had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on StemCyte recently announced quarterly report
Funding: Get notified immidiatlly once StemCyte has new funding data
Congratulate Masked Content for being promoted to Masked Content at StemCyte
Check if StemCyte has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to StemCyte
Compare insights from companies similar to StemCyte, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
StemCyte is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
StemCyte is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about StemCyte.
StemCyte financials insights
Gather financial insights about StemCyte, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$1M
2021
Debt
$963K
StemCyte Tech Stack
A closer look at the technologies used by StemCyte
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Product Development, Product Management, Legal Affairs, Governmental Affairs & Regulation, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
Funding
StemCyte has received an SBA PPP loan in the amount of $963,830 from U.S. Bank resulting in the retention of 64 jobs.
Funding
StemCyte News & Media
StemCyte Launches First Insurance-Linked Public Cord Blood Access in Taiwan, Setting a New Standard in Cell Therapy Protection
BALDWIN PARK, Calif., Nov. 5, 2025 /PRNewswire/ -- StemCyte International (TPEX: 4178), a global leader in cord blood banking and cell therapy, today announced the launch of its Public Bank Matching Protection Service in Taiwan, developed in collaboration with leading insurance partner,...StemCyte Announces Successful Phase IIa Clinical Trial Results for HPC, Cord Blood in Treating Post-COVID Syndrome: 85% of Patients Experience Complete Relief from Fatigue Symptoms
BALDWIN PARK, Calif., Dec. 19, 2024 /PRNewswire/ -- StemCyte announced a significant breakthrough in its Phase IIa clinical trial of HPC, Cord Blood (HPC, CB) for treating Post-COVID Syndrome (Long COVID). This trial results demonstrated that cord blood significantly improved fatigue...U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE™ Cord Blood Cell Therapy Product
BALDWIN PARK, Calif., Nov. 22, 2024 /PRNewswire/ -- StemCyte Inc., a wholly owned subsidiary of StemCyte International Ltd., announced today that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for its HPC, Cord Blood product REGENECYTE™, a...StemCyte's HPC Cord Blood Receives RMAT Designation for Long COVID-19 Treatment
BALDWIN PARK, Calif., Oct. 3, 2024 /PRNewswire/ -- StemCyte announced today that its Hematopoietic Progenitor Cell Cord Blood therapy (HPC Cord Blood) has officially obtained the Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for...
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding StemCyte
Sign Up For FreeTo access detailed company insights
StemCyte is a leading cord blood bank trusted by OBGYN and transplant physicians, specializing in the storage of newborn stem cells. The company offers both private and public bank access, enabling families to preserve their child's cord blood for potential life-saving treatments. StemCyte is known for its extensive and ethnically diverse inventory... Read More
